Cadaveric kidney exchange on the basis of HLA-matching is already cost-effective in the first year after grafting.
Christiaans
M H
MH
Department of Internal Medicine, University Hospital, Maastricht, The Netherlands.
van den Berg-Loonen
P M
PM
Nieman
F H
FH
Cohen
B
B
Kootstra
G
G
van Hooff
J P
JP
D003362:Cost-Benefit Analysis; D005060:Europe; D006084:Graft Rejection; D006085:Graft Survival; D006680:HLA Antigens / Q000276:immunology; D006650:Histocompatibility Testing / Q000191:economics*; D006801:Humans; D016030:Kidney Transplantation / Q000191:economics* / Q000276:immunology*; D012189:Retrospective Studies; D014015:Tissue Banks; D014184:Transplantation, Homologous
D006680:HLA Antigens